Dendur Capital LP Elanco Animal Health Inc Transaction History

Dendur Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$8.79 - $14.58 $3.69 Million - $6.12 Million	-420,000 Reduced 22.35%	1,459,078 $13.7 Million
Q4 2022 Feb 14, 2023	SELL	$11.49 - $13.65 $19.5 Million - $23.2 Million	-1,697,451 Reduced 47.46%	1,879,078 $23 Million
Q3 2022 Nov 14, 2022	BUY	$12.41 - $32.42 $2.58 Million - $6.73 Million	207,700 Added 6.17%	3,576,529 $44.4 Million
Q1 2022 May 16, 2022	BUY	$24.65 - $29.0 $24,650 - $29,000	1,000 Added 0.03%	3,368,829 $87.9 Million
Q3 2021 Nov 15, 2021	BUY	$29.2 - $36.72 $5.84 Million - $7.34 Million	200,000 Added 6.31%	3,367,829 $107 Million
Q2 2021 Aug 17, 2021	BUY	$28.76 - $35.98 $431,400 - $539,700	15,000 Added 0.48%	3,167,829 $110 Million
Q1 2021 May 17, 2021	BUY	$27.85 - $34.49 $62.6 Million - $77.5 Million	2,248,015 Added 248.45%	3,152,829 $92.9 Million
Q4 2020 Feb 16, 2021	BUY	$27.53 - $33.79 $24.9 Million - $30.6 Million	904,814 New	904,814 $27.8 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Dendur Capital LP, based on Form 13F filings with the SEC.

Stay updated on Dendur Capital LP with notifications on news.